Home / Pharmaceuticals / Bovine Respiratory Disease Treatment Market By Treatment (Vaccines, Antibiotics, Immunomodulators), By Disease, By Distribution Cannel - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Bovine Respiratory Disease Treatment Market By Treatment (Vaccines, Antibiotics, Immunomodulators), By Disease, By Distribution Cannel - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Published: May 2017 | Report Code: 58464-05-17

The purpose of this research study titled ‘Bovine Respiratory Disease Treatment Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global bovine respiratory disease treatment market. This report presents and analyzes the major trends prevalent in the global bovine respiratory disease treatment market and the market size and forecast.

This report categorizes the global bovine respiratory disease treatment market in terms of treatment type, disease type, distribution channel and geographical distribution. Based on treatment types, the global bovine respiratory disease treatment market is categorized into vaccines, antibiotics, immunomodulators and others. Pneumonia, upper respiratory tract infections and diphtheria are the major disease types considered where bovine respiratory drugs are administered. In terms of distribution channels, this market is categorized into hospitals, clinics, research institutions and others. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global bovine respiratory disease treatment market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • EU 7
    • CIS
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of disease type, treatment type, distribution channel, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global bovine respiratory disease treatment market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the industrial rubber goods market. The key players profiled in this report are Bayer AG, Boehringer Ingelheim GmbH, Bimeda, Ceva, Elanco, Merck & Co., Inc., Merial, Virbac Group, Vetoquinol, and Zoetis Services LLC.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Bovine Respiratory Disease Treatment Market Portraiture
2.1.1. Global Bovine Respiratory Disease Treatment Market, by Treatment Type, 2016
2.1.2. Global Bovine Respiratory Disease Treatment Market, by Disease Type, 2016
2.1.3. Global Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2016
2.1.4. Global Bovine Respiratory Disease Treatment Market, by Geography, 2016

Chapter 3. Bovine Respiratory Disease Treatment: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Vaccines
4.3. Antibiotics
4.4. Immunomodulators
4.5. Others

Chapter 5. Global Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Pneumonia
5.3. Upper Respiratory Tract Infections
5.4. Diphtheria

Chapter 6. Global Bovine Respiratory Disease Treatment Market, by Distribution Cannel, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. Hospitals
6.3. Clinics
6.4. Research Institutions
6.5. Others

Chapter 7. Global Bovine Respiratory Disease Treatment Market, by Geography, 2015 – 2025
7.1. Overview
7.2. North America Bovine Respiratory Disease Treatment Market Analysis, 2015 – 2025
7.2.1. North America Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.2.3. North America Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.2.4. North America Bovine Respiratory Disease Treatment Market, By Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Bovine Respiratory Disease Treatment Market Analysis, 2015 – 2025
7.3.1. Europe Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.3.3. Europe Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.3.4. Europe Bovine Respiratory Disease Treatment Market, by Region, 2015 – 2025 (US$ Mn)
7.3.4.1. E.U.7
7.3.4.2. CIS
7.3.4.3. Rest of Europe
7.4. Asia Pacific Bovine Respiratory Disease Treatment Market Analysis , 2015 – 2025
7.4.1. Asia Pacific Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Bovine Respiratory Disease Treatment Market, BY Country, 2015 – 2025 (US$ Mn)
7.4.4.1. China
7.4.4.2. India
7.4.4.3. Rest of APAC
7.5. Latin America Bovine Respiratory Disease Treatment Market Analysis , 2015 – 2025
7.5.1. Latin America Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Bovine Respiratory Disease Treatment Market Analysis, 2015 – 2025
7.6.1. MEA Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.6.3. MEA Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.6.4. MEA Bovine Respiratory Disease Treatment Products Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Bayer AG
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Boehringer Ingelheim GmbH
8.3. Bimeda
8.4. Ceva
8.5. Elanco
8.6. Merck & Co., Inc.
8.7. Merial
8.8. Virbac Group
8.9. Vetoquinol
8.10. Zoetis Services LLC
8.11. Other Notable Players

List Of Tables :

TABLE 1 Global Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 4 North America Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 7 North America Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)

List Of Figures :

FIG. 1 Bovine Respiratory Disease Treatment: Market Segmentation
FIG. 2 Global Bovine Respiratory Disease Treatment Market, by Treatment Type, 2016 (US$ Mn)
FIG. 3 Global Bovine Respiratory Disease Treatment Market, by Disease Type, 2016 (US$ Mn)
FIG. 4 Global Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2016 (US$ Mn)
FIG. 5 Global Bovine Respiratory Disease Treatment Market, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Bovine Respiratory Vaccines Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Bovine Respiratory Antibiotics Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Bovine Respiratory Immunomodulators Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Other Bovine Respiratory Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Bovine Pneumonia Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Bovine Upper Respiratory Infections Drugs Market 2015 – 2025 (US$ Mn)
FIG. 14 Global Bovine Diphtheria Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Bovine Respiratory Treatment Drugs Market in Hospitals, 2015 – 2025 (US$ Mn)
FIG. 16 Global Bovine Respiratory Disease Treatment Drugs Market in Clinics, 2015 – 2025 (US$ Mn)
FIG. 17 Global Bovine Respiratory Disease Treatment Drugs Market in Research Institutions, 2015 – 2025 (US$ Mn)
FIG. 18 Global Bovine Respiratory Disease Treatment Drugs Market in Other Distribution Channels, 2015 – 2025 (US$ Mn)

The global bovine respiratory disease treatment market is studied for the following segmentations:

  • Treatment Type  
    • Vaccine
    • Antibiotics
    • Immunomodulators
    • Others
  • Disease Type
    • Pneumonia
    • Upper Respiratory Tract Infections
    • Diphtheria
  • Distribution Channel        
    • Hospitals
    • Clinics
    • Research Institutions
    • Others

Bovine Respiratory Disease Treatment Market

Vaccines form the largest treatment type for bovine respiratory treatment. The demand for bovine respiratory disease drugs is the highest in cattle farms. In such form of animal husbandry, disease prevention have a critical status for ensuring overall cattle health and consequently operational output. Among the disease types, upper respiratory tract infections have the largest prevalence in cattle. Demand for upper respiratory tract infection drugs is the highest in emerging markets of Latin America and Asia Pacific, due to high prevalence of such infections. Hospitals form the largest distribution channel for bovine respiratory disease drugs. Local farmers and breeders often enter into long term alliances with veterinary hospitals to meet their period needs for vaccination and regular check-ups of their cattle. Clinics, on the other hand have a considerable yet fast progressing status in the market. Proliferation of drug administration from clinics is observed to be the highest in regions where the veterinary healthcare system is not yet fully established.

Geographically, the global bovine respiratory diseases treatment market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Bovine Respiratory Disease Treatment Market

Among the considered regional markets, North America currently dominates the global bovine respiratory disease treatment market, followed by Europe. Maturity of veterinary healthcare market in North America and Western Europe significantly contribute to the dominance of these regions. Other factors contributing to the success of North America and Europe markets are existence of well-structured animal husbandry industry, and ready availability of most advanced veterinary healthcare services and drugs. Asia Pacific market is anticipated to progress at the fastest growth rate during the forecast period. The growth of Asia Pacific market is majorly attributed to rapidly increasing demand for animal protein food and processed meat, substantial proliferation of animal husbandry business and evolution of veterinary healthcare infrastructure in the region. Market players have also intensified their efforts towards increasing their footprints in the untapped emerging markets in order to gain profitability and maintain competitive edge.

The detailed regional classification of the global bovine respiratory disease treatment market is as follows:

  • North America (U.S. & Canada)
  • Europe (EU 7, CIS, and Rest of Europe)
  • Asia-Pacific (China, India, and Rest of Asia Pacific)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients